UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Luspatercept Response in New Subpopulations of Patients with Lower-Risk Myelodysplastic Syndromes (MDS): Update of the Pace Study

Leukemia research, 2017-04, Vol.55, p.S31-S31

2017

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Children

The journal of clinical endocrinology and metabolism, 2004-07, Vol.89 (7), p.3234-3240

2004

Volltextzugriff (PDF)

Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

The journal of clinical endocrinology and metabolism, 1998-02, Vol.83 (2), p.379-381

1998

Volltextzugriff (PDF)

The Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Adults

The journal of clinical endocrinology and metabolism, 2002-10, Vol.87 (10), p.4508-4514

2002

Volltextzugriff (PDF)

53 LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY

Leukemia research, 2015-04, Vol.39, p.S25-S25

2015

Volltextzugriff (PDF)

Growth hormone therapy of Turner's syndrome: Beneficial effect on adult height

The Journal of pediatrics, 1998-02, Vol.132 (2), p.319-324

1998

Volltextzugriff (PDF)

Effect of Growth Hormone Treatment on Adult Height of Children with Idiopathic Short Stature

The New England journal of medicine, 1999-02, Vol.340 (7), p.502-507

1999

Volltextzugriff (PDF)

P-322 A phase 2, ascending dose study of ACE-536 to treat anemia in low/intermediate-1 risk MDS patients: The PACE-MDS study

Leukemia research, 2013-05, Vol.37, p.S167-S167

2013

Volltextzugriff (PDF)

Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone

Kidney international, 1996-03, Vol.49 (3), p.781-785

1996

Volltextzugriff (PDF)

Growth hormone therapy of Turner syndrome : The impact of age of estrogen replacement on final height

The journal of clinical endocrinology and metabolism, 2000-07, Vol.85 (7), p.2439-2445

2000

Volltextzugriff (PDF)

Mutations of the Growth Hormone Receptor in Children with Idiopathic Short Stature

The New England journal of medicine, 1995-10, Vol.333 (17), p.1093-1098

1995

Volltextzugriff (PDF)

The importance of growth hormone replacement therapy for bone mass in young adults with growth hormone deficiency

Journal of pediatric endocrinology & metabolism : JPEM, 2000-09, Vol.13 Suppl 2, p.1011

Attie, K M

2000

Volltextzugriff (PDF)

Evidence for partial growth hormone insensitivity among patients with idiopathic short stature

The Journal of pediatrics, 1995-08, Vol.127 (2), p.244-250

1995

Volltextzugriff (PDF)

Genetic studies in idiopathic short stature

Current opinion in pediatrics, 2000-08, Vol.12 (4), p.400-404

Attie, K M

2000

Volltextzugriff (PDF)

Metabolic consequences of 5-year growth hormone (GH) therapy in children treated with GH for idiopathic short stature

The journal of clinical endocrinology and metabolism, 1998-09, Vol.83 (9), p.3115-3120

1998

Volltextzugriff (PDF)

Activin stimulates spermatogonial proliferation in germ-Sertoli cell cocultures from immature rat testis

Endocrinology (Philadelphia), 1990-12, Vol.127 (6), p.3206-3214

1990

Volltextzugriff (PDF)

Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome

The Journal of pediatrics, 1992-07, Vol.121 (1), p.49-55

1992

Volltextzugriff (PDF)

National Cooperative Growth Study substudy VI: The clinical utility of growth-hormone–binding protein, insulin-like growth factor I, and insulin-like growth factor–binding protein 3 measurements

The Journal of pediatrics, 1997-07, Vol.131 (1), p.S56-S60

1997

Volltextzugriff (PDF)

FSHD / OPMD / EDMD / DMI

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S140

2018

Volltextzugriff (PDF)

FSHD / OPMD / EDMD / DMI: P.365Results for a dose-escalation phase 2 study to evaluate ACE-083, a local muscle therapeutic, in patients with facioscapulohumeral muscular dystrophy

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S140-S140

2018

Volltextzugriff (PDF)

CMT AND NEUROGENIC DISEASE: P.339Preliminary phase 2 results for ACE-083, local muscle therapeutic, in patients with CMT1 and CMTX

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S132-S133

2018

Volltextzugriff (PDF)

CMT AND NEUROGENIC DISEASE

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S132-S133

2018

Volltextzugriff (PDF)

Role of oestrogen therapy in the management of short stature in Turner syndrome

Acta Paediatrica, 1999-12, Vol.88 (s433), p.130-132

1999

Volltextzugriff (PDF)

Mutations of the growth hormone receptor--widening the search

The journal of clinical endocrinology and metabolism, 1996-05, Vol.81 (5), p.1683-1685

Attie, K M

1996

Volltextzugriff (PDF)

45 - Luspatercept Response in New Subpopulations of Patients with Lower-Risk Myelodysplastic Syndromes (MDS): Update of the Pace Study

Leukemia research, 2017-04, Vol.55, p.S31-S31

2017

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(219)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(244)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Luspatercept Response in New Subpopulations of Patients with Lower-Risk Myelodysplastic Syndromes (MDS): Update of the Pace Study

Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Children

Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

The Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Adults

53 LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY

Growth hormone therapy of Turner's syndrome: Beneficial effect on adult height

Effect of Growth Hormone Treatment on Adult Height of Children with Idiopathic Short Stature

P-322 A phase 2, ascending dose study of ACE-536 to treat anemia in low/intermediate-1 risk MDS patients: The PACE-MDS study

Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone

Growth hormone therapy of Turner syndrome : The impact of age of estrogen replacement on final height

Mutations of the Growth Hormone Receptor in Children with Idiopathic Short Stature

The importance of growth hormone replacement therapy for bone mass in young adults with growth hormone deficiency

Evidence for partial growth hormone insensitivity among patients with idiopathic short stature

Genetic studies in idiopathic short stature

Metabolic consequences of 5-year growth hormone (GH) therapy in children treated with GH for idiopathic short stature

Activin stimulates spermatogonial proliferation in germ-Sertoli cell cocultures from immature rat testis

Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome

National Cooperative Growth Study substudy VI: The clinical utility of growth-hormone–binding protein, insulin-like growth factor I, and insulin-like growth factor–binding protein 3 measurements

FSHD / OPMD / EDMD / DMI

FSHD / OPMD / EDMD / DMI: P.365Results for a dose-escalation phase 2 study to evaluate ACE-083, a local muscle therapeutic, in patients with facioscapulohumeral muscular dystrophy

CMT AND NEUROGENIC DISEASE: P.339Preliminary phase 2 results for ACE-083, local muscle therapeutic, in patients with CMT1 and CMTX

CMT AND NEUROGENIC DISEASE

Role of oestrogen therapy in the management of short stature in Turner syndrome

Mutations of the growth hormone receptor--widening the search

45 - Luspatercept Response in New Subpopulations of Patients with Lower-Risk Myelodysplastic Syndromes (MDS): Update of the Pace Study

Suchergebnisse filtern